SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined…

Entrada Therapeutics, Inc. · CLUSTER filed Aug 31, 2026 at 18:26 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 31, 2026 at 18:26 ET

Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined 88.5K shares for ~$619K in open-market sales over two days, while the CEO had a routine tax-withholding transaction. The selling is modest at ~0.22% of market cap, and as a cluster of sells by non-C-suite insiders, it carries limited predictive signal per academic literature.

  • Two MPM BioVentures entities (10% owners) sold 44,259 shares each on 2026-08-31 at $6.99, totaling ~$618K
  • CEO Doshi Dipal had a routine tax-withholding transaction of 8,724 shares on 2026-09-02 with no open-market activity
  • Total open-market selling of ~$618K represents ~0.22% of TRDA's $284M market cap
  • No C-suite executives engaged in open-market sales; selling is limited to venture capital 10% owners

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access